中文摘要：

背景：大量研究表明CD4＋CD25＋Foxp3＋ 调节性T细胞与口服耐受和动脉粥样硬化抑制有关,然而有关经鼻耐受是否也有同样效应的报道较少.目的：分析热休克蛋白65经鼻诱导免疫耐受对动脉粥样硬化的影响及其机制.方法：6周龄ApoE基因敲除小鼠经鼻给予热休克蛋白65（实验组）或磷酸盐缓冲液（对照组）,待小鼠16周龄时行冰冻切片测定小鼠主动脉根部粥样硬化斑块面积;流式细胞学检测小鼠体内CD4＋CD25＋Foxp3＋ 调节性T细胞水平;ELISA检测转化生长因子β水平.结果与结论：经鼻给药后8周,实验组小鼠主动脉根部斑块面积较对照组明显减少,下降约32.7%（P 〈 0.01）;经鼻给药14 d后,实验组小鼠CD4＋CD25＋Foxp3＋调节性T细胞较对照组明显增加（P 〈 0.01）;经鼻给药第4,14天和8周,实验组转化生长因子β表达显著高于对照组.表明鼻饲热休克蛋白65通过诱导依赖抗炎因子转化生长因子β作用的调节性T细胞的产生建立免疫耐受,进一步抑制动脉粥样硬化形成,推测热休克蛋白65经鼻诱导免疫耐受是口服诱导免疫耐受之外另一种有效的抑制动脉粥样硬化的方法.

英文摘要：

BACKGROUND： A body of evidences support that CD4＋CD25＋Foxp3＋ regulatory T cells is associated with oral tolerance induction and inhibition of atherosclerosis, but little is described whether nasal tolerance to antigen likewise induce the regulatory T cell production and antiatherosclerotic benefit. OBJECTIVE： To investigate the effect of nasal tolerance induction to heat shock protein-65 （HSP65） on atherogenesis and potential mechanism. METHODS： Six-week-old male ApoE-/- mice were nasally administrated HSP65 or phosphate buffer as control. Cryo-section was used to examine the size of atheromatous plaque area of aortic root in ApoE-/- mice with sixteen-week-old; fluorescence activated cell sorter was used to analyse the production level of CD4＋CD25＋Foxp3＋ regulatory T cells; ELISA was applied to determine the level of cytokines transforming growth factor beta （TGF-β）. RESULTS AND CONCLUSION： Eight weeks after nasal administration, the results of cryo-section showed that HSP65-treated mice had a marked decrease by 32.7% in atheromatous plaque area of aortic root as compared with the control group （P 〈 0.01）. At 14 days after the last nasal treatment, the percentage of CD4＋CD25＋Foxp3＋ regulatory T cells in total CD4＋ T cells from treated mice increased significantly as compared with the control group （P 〈 0.01）, at 4,14 days and 8 weeks after the last nasal administration, cytokine TGF-β level from nasal HSP65 mice increased remarkably compared with the control group on the above three points. So, nasal tolerance induction to heat shock protein-65 inhibits atherosclerotic formation by inducing anti-inflammatory cytokine TGF-β-dependent regulatory T cells. It is proposed that nasal tolerance induction to HSP65 may provide an alternative therapeutic method to atherosclerosis.